Clinical Trials List
2020-01-11 - 2027-12-31
Phase III
Recruiting6
-
Trial Applicant
AbbVie
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- 唐世豪 無
- Jeng-Shiun Du 無
- Yi-Chang Liu 無
- Shih-Feng Cho 無
- Hui-Ching Wang 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- CHENG-HONG TSAI 無
- Huai-Hsuan Huang 無
- Chien-Chin Lin 無
- Jih-Luh Tang 無
- HSIN-AN HOU 無
- 劉家豪 無
- YAO CHI-YUAN 無
- 田豐銘 無
- Chieh-Lung Cheng 無
- MING YAO 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Po-Nan Wang 未分科
- Ming-Chung Kao 無
- Tung-Liang Lin 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Jyh-Pyng Gau 無
- Liang-Tsai Hsiao 無
- Hao-Yuan Wang 無
- 陳玟均 無
- Sheng-Hsuan Chien 無
- Ting-An Lin 無
- Chia-Jen Liu 無
- Po-Shen Ko 無
- 蔡淳光 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
20 participants
-
Global
424 participants
